[Our experience with Acépreval a new topical non-fluorinated cortisone in dermatological therapy].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004485:Eczema / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D006801:Humans; D011239:Prednisolone; D011565:Psoriasis / Q000188:drug therapy; D012393:Rosacea / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D014631:Valerates / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D014631:Valerates; D005446:Fluocinolone Acetonide; D011239:Prednisolone
Notre expérience avec Acépréval, un nouveau cortisonique topique non fluoriné, en thérapie dermatologique.